Marcella Barbarino

1.3k total citations
35 papers, 1.0k citations indexed

About

Marcella Barbarino is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marcella Barbarino has authored 35 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marcella Barbarino's work include Histone Deacetylase Inhibitors Research (5 papers), Occupational and environmental lung diseases (5 papers) and Osteoarthritis Treatment and Mechanisms (5 papers). Marcella Barbarino is often cited by papers focused on Histone Deacetylase Inhibitors Research (5 papers), Occupational and environmental lung diseases (5 papers) and Osteoarthritis Treatment and Mechanisms (5 papers). Marcella Barbarino collaborates with scholars based in Italy, United States and United Kingdom. Marcella Barbarino's co-authors include Antonio Giordano, Claudio Pisano, Loredana Vesci, Sara Cheleschi, Antonella Fioravanti, Stefano Giannotti, Sara Tenti, Paolo Carminati, Giuseppe Giannini and Federica Bucci and has published in prestigious journals such as Cancer Research, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Marcella Barbarino

34 papers receiving 998 citations

Peers

Countries citing papers authored by Marcella Barbarino

Since Specialization

Citations

This map shows the geographic impact of Marcella Barbarino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcella Barbarino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcella Barbarino more than expected).

Fields of papers citing papers by Marcella Barbarino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcella Barbarino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcella Barbarino. The network helps show where Marcella Barbarino may publish in the future.

Co-authorship network of co-authors of Marcella Barbarino

This figure shows the co-authorship network connecting the top 25 collaborators of Marcella Barbarino. A scholar is included among the top collaborators of Marcella Barbarino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcella Barbarino. Marcella Barbarino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MicroRNA as Possible Mediators of the Synergistic Effect of Celecoxib and Glucosamine Sulfate in Human Osteoarthritic Chondrocyte Exposed to IL-1β 2023 ·International Journal of Molecular Sciences ·Sara Cheleschi, Nicola Veronese, Serafino Carta, Giulia Collodel, (unknown), Elena Moretti, Roberta Corsaro, Marcella Barbarino, Antonella Fioravanti	2
2	A Drug Screening Revealed Novel Potential Agents against Malignant Pleural Mesothelioma 2022 ·Cancers ·(unknown), (unknown), Sarah A. Martin, Marcella Barbarino, (unknown), Monica Cipollini, Antonio Giordano, Luciano Mutti, Andrea Nicolini, Luca Luzzi, (unknown), Federica Gemignani, Stefano Landi	12
3	Analysis of Primary Cilium Expression and Hedgehog Pathway Activation in Mesothelioma Throws Back Its Complex Biology 2022 ·Cancers ·Marcella Barbarino, (unknown), (unknown), Maria Margherita De Santi, (unknown), (unknown), (unknown), Gabriella Serio, Francesco Iannelli, (unknown), (unknown), (unknown), (unknown), Luca Luzzi, Cristiana Bellan, Antonio Giordano	2
4	Mesothelioma Malignancy and the Microenvironment: Molecular Mechanisms 2021 ·Cancers ·(unknown), Marcella Barbarino, Silvia Lonardi, William Vermi, Antonio Giordano, Cristiana Bellan, Emanuele Giurisato	23
5	Assessment of the Carcinogenicity of Carbon Nanotubes in the Respiratory System 2021 ·Cancers ·Marcella Barbarino, Antonio Giordano	38
6	EIF4G1 and RAN as Possible Drivers for Malignant Pleural Mesothelioma 2020 ·International Journal of Molecular Sciences ·(unknown), Marcella Barbarino, Elisa Barone, Antonio Giordano, Luca Luzzi, (unknown), (unknown), (unknown), (unknown), Ombretta Melaiu, (unknown), Monica Cipollini, (unknown), Alda Corrado, Federica Gemignani, Stefano Landi	11
7	Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma 2020 ·Investigational New Drugs ·(unknown), Sarah A. Martin, Marcella Barbarino, (unknown), (unknown), (unknown), Elisa Paolicchi, Alda Corrado, Monica Cipollini, Ombretta Melaiu, Antonio Giordano, Luca Luzzi, Federica Gemignani, Stefano Landi	7
8	MicroRNA-34a and MicroRNA-181a Mediate Visfatin-Induced Apoptosis and Oxidative Stress via NF-κB Pathway in Human Osteoarthritic Chondrocytes 2019 ·Cells ·Sara Cheleschi, Sara Tenti, Nicola Mondanelli, Claudio Corallo, Marcella Barbarino, Stefano Giannotti, (unknown), Antonio Giordano, Antonella Fioravanti	66
9	TGF-β concentrations and activity are down-regulated in the aqueous humor of patients with neovascular age-related macular degeneration 2018 ·Scientific Reports ·Gian Marco Tosi, Giovanni Neri, (unknown), (unknown), Tommaso Bacci, (unknown), (unknown), Davide Marigliani, Stefano Baiocchi, Claudio Traversi, Marcella Barbarino, Chiara M. Eandi, Barbara Parolini, Lucia Mundo, Annalisa Santucci, Maurizio Orlandini, Federico Galvagni	24
10	Flavopiridol: An Old Drug With New Perspectives? Implication for Development of New Drugs 2016 ·Journal of Cellular Physiology ·Annamaria Cimini, Michele d’Angelo, Elisabetta Benedetti, Barbara D’Angelo, Giulio Laurenti, Andrea Antonosante, Loredana Cristiano, (unknown), Marcella Barbarino, Vanessa Castelli, Benedetta Cinque, Maria Grazia Cifone, Rodolfo Ippoliti, Francesca Pentimalli, Antonio Giordano	21
11	Novel PARP-1 inhibitors based on a 2-propanoyl-3H-quinazolin-4-one scaffold 2013 ·Bioorganic & Medicinal Chemistry Letters ·Giuseppe Giannini, Gianfranco Battistuzzi, Loredana Vesci, Ferdinando Maria Milazzo, (unknown), Marcella Barbarino, Mario B. Guglielmi, (unknown), Grazia Gallo, Roberto Artali, Sabrina Dallavalle	31
12	Isoxazolo(aza)naphthoquinones: A new class of cytotoxic Hsp90 inhibitors 2012 ·European Journal of Medicinal Chemistry ·Alberto Bargiotti, Loana Musso, Sabrina Dallavalle, Lucio Merlini, Grazia Gallo, Andrea Ciacci, Giuseppe Giannini, Walter Cabri, Sergio Penco, Loredana Vesci, Massimo Castorina, Ferdinando Maria Milazzo, (unknown), Marcella Barbarino, Claudio Pisano, Chiara Giommarelli, Valentina Zuco, Michelandrea De Cesare, Franco Zunino	32
13	Efficient organic monoliths prepared by γ-radiation induced polymerization in the evaluation of histone deacetylase inhibitors by capillary(nano)-high performance liquid chromatography and ion trap mass spectrometry 2011 ·Journal of Chromatography A ·(unknown), Marcella Barbarino, Walter Cabri, Ilaria D’Acquarica, (unknown), Francesco Gasparrini, Fabrizio Giorgi, Marco Pierini, Patrizia Simone, Ornella Ursini, Claudio Villani	16
14	Metabolic Approach to the Enhancement of Antitumor Effect of Chemotherapy: a Key Role of Acetyl- l -Carnitine 2010 ·Clinical Cancer Research ·Claudio Pisano, Loredana Vesci, Ferdinando Maria Milazzo, Mario B. Guglielmi, (unknown), Marcella Barbarino, Maurizio D’Incalci, Massimo Zucchetti, Giovanna Petrangolini, Monica Tortoreto, Paola Perego, Valentina Zuco, Augusto Orlandi, Daniela Passeri, Paolo Carminati, (unknown), Franco Zunino	24
15	ω-Alkoxy analogues of SAHA (vorinostat) as inhibitors of HDAC: A study of chain-length and stereochemical dependence 2007 ·Bioorganic & Medicinal Chemistry Letters ·Stephen Hanessian, Luciana Auzzas, Giuseppe Giannini, Mauro Marzi, Walter Cabri, Marcella Barbarino, Loredana Vesci, Claudio Pisano	26
16	Development of Resistance to the Atypical Retinoid, ST1926, in the Lung Carcinoma Cell Line H460 Is Associated with Reduced Formation of DNA Strand Breaks and a Defective DNA Damage Response 2005 ·Neoplasia ·Valentina Zuco, Chiara Zanchi, Cinzia Lanzi, Giovanni Luca Beretta, Rosanna Supino, Claudio Pisano, Marcella Barbarino, (unknown), Federica Bucci, (unknown), Paolo Carminati, Franco Zunino	26
17	Novel Camptothecin Analogue (Gimatecan)‐Containing Liposomes Prepared by the Ethanol Injection Method 2004 ·Journal of Liposome Research ·Pasquale Stano, Simone Bufali, Claudio Pisano, Federica Bucci, Marcella Barbarino, (unknown), Paolo Carminati, Pier Luigi Luisi	86
18	Inhibition of Telomerase Increases Resistance of Melanoma Cells to Temozolomide, but Not to Temozolomide Combined with Poly (ADP-Ribose) Polymerase Inhibitor 2003 ·Molecular Pharmacology ·Lucio Tentori, Ilaria Portarena, Marcella Barbarino, Alessandra Balduzzi, Lauretta Levati, Matteo Vergati, Annamaria Biroccio, Barry Gold, Maria Luisa Lombardi, Grazia Graziani	30
19	Critical role of both p27^KIP1and p21^CIP1/WAF1 in the antiproliferative effect of ZD1839 (‘Iressa’), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells 2003 ·Journal of Cellular Physiology ·Elena Di Gennaro, Marcella Barbarino, Francesca Bruzzese, Sonya De Lorenzo, Michele Caraglia, Alberto Abbruzzese, Antonio Avallone, Pasquale Comella, Francesco Caponigro, Stefano Pepe, Alfredo Budillon	114
20	CRH Inhibits Cell Growth of Human Endometrial Adenocarcinoma Cells via CRH-Receptor 1-Mediated Activation of cAMP-PKA Pathway 2002 ·Endocrinology ·Grazia Graziani, Lucio Tentori, Ilaria Portarena, Marcella Barbarino, Giuseppe Tringali, Giacomo Pozzoli, Pierluigi Navarra	63

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact